pepmg_

Study summary · research use only

Ghrelin receptor agonist hexarelin attenuates antinociceptive tolerance to morphine in rats

Study · Canadian journal of physiology and pharmacology · 2021 · DOI 10.1139/cjpp-2020-0218 · PMID 32893668

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

In this rat study using 104 Wistar albino male rats weighing approximately 220-240 g, the effects of the ghrelin receptor agonist hexarelin (0.2 mg/kg) and antagonist [d-Lys3]-GHRP-6 (10 mg/kg) on morphine (5 mg/kg) antinociception and tolerance were evaluated using a three-day cumulative dosing regimen and tail-flick and hot-plate tests at 30-min intervals (0, 30, 60, 90, and 120 min). The abstract reports that hexarelin combined with morphine attenuated analgesic tolerance to morphine and increased the analgesic effect, while [d-Lys3]-GHRP-6 showed no significant analgesic activity on its own. The authors describe hexarelin as enhancing antinociception and attenuating morphine tolerance when co-administered with morphine.

Abstract

Ghrelin, a peptide hormone released from the gastric endocrine glands, shows analgesic activity apart from its various physiological effects. Nevertheless, the effects of ghrelin receptor (GHS-R) agonists on morphine analgesia and tolerance have not yet been elucidated. The purpose of this study was to evaluate the effects of the ghrelin receptor agonist hexarelin and antagonist [d-Lys3]-GHRP-6 on morphine antinociception and tolerance in rats. A total of 104 Wistar albino male adult rats (weighing approximately 220-240 g) were used in the experiments. To induce morphine tolerance, a three-day cumulative dose regimen was used in the rats. Then, randomly selected rats were evaluated for morphine tolerance on day 4. The analgesic effects of hexarelin (0.2 mg·kg-1), [d-Lys3]-GHRP-6 (10 mg·kg-1), and morphine (5 mg·kg-1) were measured at 30-min intervals (0, 30, 60, 90, and 120 min) by tail-flick and hot-plate analgesia tests. The findings suggest that hexarelin in combination with morphine attenuates analgesic tolerance to morphine. On the other hand, ghrelin receptor antagonist [d-Lys3]-GHRP-6 has no significant analgesic activity on the morphine tolerance in analgesia tests. Furthermore, co-administration of hexarelin and morphine increases the analgesic effect. In conclusion, these data indicate that administration of GHS-R agonist hexarelin with morphine enhances the antinociception and attenuates morphine tolerance.

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.